000 | 01325 a2200373 4500 | ||
---|---|---|---|
005 | 20250515164217.0 | ||
264 | 0 | _c20090416 | |
008 | 200904s 0 0 eng d | ||
022 | _a0250-7005 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFlis, Sylwia | |
245 | 0 | 0 |
_aInhibitory effects of 5-fluorouracil and oxaliplatin on human colorectal cancer cell survival are synergistically enhanced by sulindac sulfide. _h[electronic resource] |
260 |
_bAnticancer research _cJan 2009 |
||
300 |
_a435-41 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 | _aBALB 3T3 Cells |
650 | 0 | 4 |
_aCell Cycle _xdrug effects |
650 | 0 | 4 |
_aCell Growth Processes _xdrug effects |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
650 | 0 | 4 | _aHT29 Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aOrganoplatinum Compounds _xadministration & dosage |
650 | 0 | 4 | _aOxaliplatin |
650 | 0 | 4 |
_aSulindac _xadministration & dosage |
700 | 1 | _aSpłwiński, Jacek | |
773 | 0 |
_tAnticancer research _gvol. 29 _gno. 1 _gp. 435-41 |
|
999 |
_c18767634 _d18767634 |